Q4 2025 Holdings
Filed 2026-02-17 | 13 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $319.8M | 9,003,418 | 24.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $154.6M | 2,048,647 | 11.8% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $131.6M | 4,018,101 | 10.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $121.8M | 3,914,458 | 9.3% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $112.3M | 3,705,262 | 8.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $88.1M | 2,137,191 | 6.7% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $80.2M | 2,209,025 | 6.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $73.2M | 727,563 | 5.6% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $70.3M | 4,553,494 | 5.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $57.2M | 3,711,444 | 4.4% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $54.4M | 1,319,688 | 4.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $32.6M | 2,747,866 | 2.5% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $17.7M | 8,625,000 | 1.3% |